Definitive Tumor Resection after Myeloablative High Dose Chemotherapy Is a Feasible and Effective Option in the Multimodal Treatment of High-Risk Neuroblastoma: A Single Institution Experience-Reference-Cited by-同舟云学术

Definitive Tumor Resection after Myeloablative High Dose Chemotherapy Is a Feasible and Effective Option in the Multimodal Treatment of High-Risk Neuroblastoma: A Single Institution Experience

Published:2020-08 Issue:8 Volume:55 Page:1655-1659
ISSN:0022-3468
Container-title:Journal of Pediatric Surgery
language:en
Short-container-title:Journal of Pediatric Surgery

Author:

Hishiki Tomoro,Fujino Akihiro,Watanabe Toshihiko,Tahara Kazunori,Ohno Michinobu,Yamada Yohei,Tomonaga Kotaro,Kutsukake Mai,Fujita Takuro,Kawakubo Naonori,Matsumoto Kimikazu,Kiyotani Chikako,Shioda Yoko,Miyazaki Osamu,Fuji Hiroshi,Yoshioka Takako,Kanamori Yutaka

Funder

JSPS KAKENHI Grant-in-Aid for Scientific Research

Publisher

Elsevier BV

Subject

General Medicine,Pediatrics, Perinatology, and Child Health,Surgery

Reference24 articles.

1. The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment;Bolande;Hum Pathol,1974

2. Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG);Hishiki;Int J Clin Oncol,2018

3. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;N Engl J Med,1999

4. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial;Pearson;Lancet Oncol,2008

5. SIOP Europe Neuroblastoma Group (SIOPEN). Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial;Ladenstein;Lancet Oncol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and Risk Factors for Chyle Leaks After Neuroblastic Tumor Resection: A Systematic Review of Published Studies;Journal of Pediatric Surgery;2024-08

2. Should Pediatric Surgical Oncologists Receive Training in Vascular Surgery ? A Practice Survey Report From the International Society of Paediatric Surgical Oncology (IPSO);Journal of Pediatric Surgery;2024-08

3. LncRNA SNHG4 promotes neuroblastoma proliferation, migration, and invasion by sponging miR-377-3p;Neoplasma;2020

4. Minimally invasive surgery to treat embryonal tumors of childhood;Cancer and Metastasis Reviews;2019-12